NCRI 2014

Dr Faivre-Finn talks to ecancertv at NCRI 2014 about the role of thoracic radiotherapy in patients who have extensive stage small cell lung cancer. It was found to improve survival and was well tolerated.

Dr Lewis talks to ecancertv at NCRI 2014 about the therapeutic benefits brought about by singing in a choir, based on research carried out on participants of Tenovus-initiated choirs in Wales.

Prof Adam talks to ecancertv at NCRI 2014 about interventional oncology which joins surgery, radiation oncology and medical oncology and focuses on minimally invasive image-guided methods to locally destroy tumours using various forms of energy such as radio frequency waves and micro-waves.

Prof Cree talks to ecancertv at NCRI 2014 about the possibility of blood-based screening for cancer behalf of the Early Cancer Detection Consortium.

Dr Kennedy talks to ecancertv at the 10th NCRI Cancer Conference (NCRI 2014) about some of the collaborative research initiatives that NCRI (the National Cancer research Institute) promotes and facilitates and why they are so important.

Prof Biankin talks to ecancertv at NCRI 2014 about the advancement of cancer genomics via cross-institutional collaboration, with specific reference to pancreatic cancer and the difficulty in finding biomarkers.

Helen French talks to ecancertv at NCRI 2014 about how counselling services are accessed differently by men and women, with reference to socialised behaviours and mentalities – some of which can be useful but others less so. Men, on the whole, were less likely to seek help than women, but once they did they made progress more quickly than women, perhaps due to a "let's fix this" attitude.

Dr Cantley talks to ecancertv at NCRI 2014 about a multi-institution study of women's cancers and the ways in which a particular enzyme, PI3K, influences risk and how it might be targeted.

Dr Brown talks to ecancertv at NCRI 2014 about the discovery and development of new agents derived from both dietary and drug sources for their anti-cancer properties. In particular she gives insight on work she has done looking at red wine and colorectal cancer, as well as turmeric and aspirin among others.

Dr Murray talks to ecancertv at NCRI 2014 about how changes in small pieces of genetic code in malignant germ cell tumours can be found in the blood stream, and how this work has been extended to common solid tumours of childhood, with the aim to assist diagnosis and personalise treatment.

Dr Parada talks to ecancertv at NCRI 2014 about the ways in which mice can be used to investigate the causes of malignant brain tumours.

Prof Marais talks to ecancertv at NCRI 2014 about the highlights of this year's conference and what the future may hold.

Prof Kuhn talks to ecancertv at NCRI 2014 about a multidisciplinary approach to oncology involving maths, physics, biology, medicine and engineering, with a particular focus on lung cancer screening.

Prof Vedsted talks to ecancertv at NCRI 2014 about the importance of early cancer diagnosis and awareness among the population about signs to watch out for. In particular, he highlights the importance of the accessibility and rigorousness of general practitioners as they are the first port-of-call for potential cancer patients, and outlines some of the initiatives in place to enhance the service they provide.

Prof Timmerman talks to ecancertv at NCRI 2014 about new radiotherapy techniques which target cancer more precisely, sparing the surrounding tissue from the "collateral" damage that was previously a significant issue.

Roger Wilson talks to ecancertv at NCRI 2014 about patient advocacy at the conference and the concept of a "Dragon's Den"-esque competition to pitch research ideas, a proposal on stratified medicine being his personal choice.

Prof Fitzgerald talks to ecancertv at NCRI 2014 about the results of a study which looked at a novel detection device for cancer of the oesophagus. The test was found to be well-tolerated and highly accurate.

Prof Laskey talks to ecancertv at NCRI 2014 about the Lifetime Achievement Prize he received from Cancer Research UK, and gives us an insight into some of the valuable research he's done to earn it.

Dr Cagan talks to ecancertv at NCRI 2014 about the use of fly models to sequence and develop treatments for cancers.

Dr Koller talks to ecancertv at NCRI 2014 about cancer metaphors, such as those relating to journeys or war, and their psychosocial impacts on patients and their families.

Prof Treasure talks to ecancertv at NCRI 2014 about recurrent colorectal cancer which has spread to the lungs or liver and the questions raised over the efficacy of current treatment practices involving surgery, which may or may not be beneficial.

Dr Breitbart talks to ecancertv at NCRI 2014 about psycho-oncology and the often overlooked importance of addressing issues surrounding meaning and purpose in cancer patients experiencing anxiety or depression. He suggests that looking at meaning as an alterative approach to anti-depressants may be more effective for those who are not clinically depressed but are, rather, experiencing "a profound loss of meaning".